As of Jul 02
| +0.08 / +2.21%|
The 3 analysts offering 12-month price forecasts for Oncothyreon Inc have a median target of 4.00, with a high estimate of 5.00 and a low estimate of 4.00. The median estimate represents a +8.11% increase from the last price of 3.70.
The current consensus among 4 polled investment analysts is to Buy stock in Oncothyreon Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.